US Diabetes Market Trends Influencing Disease Management Strategies
The therapeutic segment of the US Diabetes Market is undergoing significant structural changes due to the entry of complex biologics and biosimilar options. As foundational patents for long-standing insulin formulations expire, the market is opening to alternative manufacturers, creating downward pressure on prices and expanding options for patients. This shift is altering traditional pharmacy...
0 Commentaires 0 Parts 3 Vue 0 Aperçu